STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACHV
  4. [Form 4] ACHIEVE LIFE SCIENCES, INC. Insider Trading Activity

Director awards at Achieve Life Sciences (NASDAQ: ACHV) include options, RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Waldman Reid Alexander reported acquisition or exercise transactions in this Form 4 filing.

Achieve Life Sciences, Inc. director Reid Alexander Waldman received equity compensation on July 27, 2026, consisting of 25,000 stock options to buy common stock at $6.18 per share, expiring July 27, 2036, and 16,700 RSUs. Both awards vest 100% on the earlier of July 27, 2027 or immediately prior to the 2027 annual meeting, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Waldman Reid Alexander
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1 25,000 $0.00 $0.00
Grant/Award Restricted Stock Unit (RSU) F2, F3 16,700 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 25,000 shares (Direct); Restricted Stock Unit (RSU) — 16,700 shares (Direct)
Footnotes (3)
  1. F1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
  2. F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
  3. F3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Stock options granted 25,000 shares Director equity award dated 2026-07-27
Option exercise price $6.18 per share Stock Option (right to buy) grant
RSUs granted 16,700 units Restricted Stock Unit grant dated 2026-07-27
Option expiration July 27, 2036 Expiration date of granted stock options
Vesting date trigger July 27, 2027 Awards vest on this date or immediately prior to 2027 annual meeting
Restricted Stock Unit (RSU) financial
"Restricted Stock Unit (RSU) represents a contingent right to receive one share"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
Stock Option (right to buy) financial
"Stock Option (right to buy) exercisable at $6.18 per share"
vest 100% financial
"the options vest 100% on the earlier of July 27, 2027"
contingent right to receive financial
"Each RSU represents a contingent right to receive one share"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What equity awards did ACHV director Reid Alexander Waldman receive on July 27, 2026?
Reid Alexander Waldman received 25,000 stock options to buy Achieve Life Sciences common stock at $6.18 per share and 16,700 restricted stock units (RSUs) on July 27, 2026, as part of his director equity compensation.

What are the vesting terms of the new ACHV stock options and RSUs?
Both the 25,000 stock options and 16,700 RSUs vest 100% on the earlier of July 27, 2027 or the date immediately prior to Achieve Life Sciences’ 2027 annual stockholders’ meeting, contingent on Waldman continuing to provide service through the vesting date.

What is the exercise price and expiration date of Waldman’s ACHV stock options?
The granted stock options allow Waldman to buy Achieve Life Sciences common stock at an exercise price of $6.18 per share and are scheduled to expire on July 27, 2036, if not exercised or forfeited earlier under plan terms.

How many shares of ACHV common stock does each RSU represent?
Each restricted stock unit granted to Waldman represents a contingent right to receive one share of Achieve Life Sciences common stock upon settlement, meaning 16,700 RSUs correspond to up to 16,700 common shares if fully vested and settled.

Were Waldman’s ACHV equity awards granted under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not checked, so these equity awards are not reported as being made pursuant to a Rule 10b5-1 trading plan; they are standard director compensation grants.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Waldman Reid Alexander
(Last)(First)(Middle)
22722 29TH DR. SE
SUITE 100
(Street)
BOTHELL WASHINGTON 98021
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$6.1807/27/2026A25,000 (1)07/27/2036Common Stock25,000$025,000D
Restricted Stock Unit (RSU)(2)07/27/2026A16,700 (3)07/27/2036Common Stock16,700$016,700D
Explanation of Responses:
1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Sandra Thomson as attorney-in-fact07/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR